This Solicitation opportunity from Department Of Defense was posted on September 2, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

MEFLOQUINE HYDROCHL

Closed

SPE2DP-26-T-4862Federal

Submission Closed09/08/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

Manufacturer of Ultrasonic Dental Cleaning CompoundsThis subcontract involves the chemical formulation and production of Maxizyme enzyme cleaning tablets intended for prime contractors supporting Defense Logistics Agency medical supply contracts. The scope of work encompasses the full manufacturing process, including chemical synthesis, the formulation of enzyme cleaners specifically for ultrasonic dental cleansing, and the compression of these compounds into final tablet form using specialized chemical processing equipment and tablet presses. The manufacturer is required to adhere strictly to the DLA Master List of Technical and Quality Requirements as well as Medical Marking Standard No. 1 to ensure regulatory compliance. The final deliverable consists of packaged Maxizyme Tablets provided to the Department of Defense via the Medical Supply Chain. This opportunity falls under NAICS code 325412 and is managed through the DLA system.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970-01-258-1216)This subcontract involves the supply of electrical insulation tape for prime contractors working under the Defense Logistics Agency Weapons Support ASC Supplier Oper AE and AF Division. The selected provider is responsible for manufacturing or sourcing tape that strictly adheres to technical specifications for NSN 5970-01-258-1216. All deliverables must be packaged according to RP001 standards and marked and labeled in compliance with RQ017 requirements, necessitating the use of packaging facilities capable of meeting these specific DLA standards. The opportunity is categorized under NAICS code 325412 and is managed by the Department of Defense. Performance of the contract will take place in APO 96328-5120. Interested parties must note the response deadline of October 26, 2026, to submit their proposals for the delivery of these physical materials.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Supply of Orange Flavored Electrolyte Oral Hydration PowderThis subcontract involves the manufacture or distribution of medical-grade orange-flavored electrolyte oral hydration powder to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The required product must meet NSN 6505016871441, provided in 21 GM units packaged in quantities of 100, while adhering to Medical Marking Standard No. 1 and commercial packing standards. The contract mandates strict compliance with the Buy American Act, the Berry Amendment, and NIST SP 800-171 cybersecurity standards. Performance takes place at FPO 09591-2600, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lactated Ringer's InjectionThis subcontract involves the supply of Lactated Ringer's Injection, USP, 1000ML, 12S for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The selected provider must manufacture or wholesale these medical fluids in accordance with USP standards and FDA regulations, ensuring a minimum shelf life of 30 months. All products must be packaged in commercial sealed units following MIL-STD-2073-1E and RP001 guidelines and marked according to Medical Marking Standard No. 1. The contract requires delivery of completed orders FOB Destination to a performance location in FPO 96660. Interested parties must respond by October 26, 2026, for this requirement categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

RINGER'S INJECTION, LAC

Solicitation # SPE2DP-27-T-0121

Solicitation SPE2DP-27-T-0121 is a request for quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Ringer's Injection, Lactated, USP, 1000ML, 12S, identified by NSN 6505013306267. The requirement consists of one package (PG) with a delivery timeline of 20 days after order, and an original required delivery date of October 20, 2026. Delivery is FOB Destination, with shipping addresses including USNS Able T-AGOS 20 and locations in Colchester, Vermont. The item is regulated by the FDA and has a non-extendable shelf life of 30 months. Packaging must be commercial and compliant with MIL-STD-2073-1E and RP001, with specific requirements to use sealed unit containers to prevent damage. Marking must adhere to Medical Marking Standard No. 1, which supersedes MIL-STD-129. Storage requires protection from freezing and excessive heat, with a recommended room temperature of 25 degrees Celsius. The contract incorporates several federal regulations, including the Buy American and Balance of Payments Program, basic safeguarding of covered contractor information systems, and the Hazard Communication Standard for any hazardous materials. Invoicing must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DS-27-T-0734

Solicitation SPE2DS-27-T-0734 is a request for quotations issued by the DLA Troop Support Medical Supply Chain for the procurement of five blue medicine balls used for physical therapy. The required items must have a nominal diameter of 7 inches and a weight of 6.6 lbs (3 kg), corresponding to NSN 7830016007777 and part number A926115. Delivery is required within five days after receipt of the order, with the shipping destination specified as Rose Barracks South Camp in Germany. The contract is established as FOB Destination, and inspection and acceptance will also occur at the destination. The contractor must adhere to strict packaging and marking standards, specifically utilizing Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must be commercial grade, with each unit in a sealed container to prevent damage. The procurement is governed by various FAR and DFARS clauses, including those regarding the Buy American Act, the Berry Amendment, and cybersecurity requirements under DFARS 252.204-7012. Invoicing and payment must be processed electronically through the Wide Area WorkFlow system. Offerors are required to submit quotes via the DIBBS portal and must maintain active registration in the System for Award Management.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

CHLORINE TEST REAGENT

Solicitation # SPE2DS-27-T-0723

Solicitation SPE2DS-27-T-0723 is a fixed-price procurement issued by the Department of Defense Medical Supply Chain for the supply of Chlorine Test Reagent (NSN 6550-01-460-7597). The requirement is for two packages, with each package containing 100 powder pillows for a 10 ML sample size using DPD Total Chlorine Reagent. Delivery is required within 5 days after receipt of order, with a specified delivery date of October 20, 2026, and the place of performance located in Pascagoula, Mississippi. The contract mandates strict quality and shelf-life requirements, specifying a non-extendable shelf life of 60 months, with no more than 8 months elapsed from the date of manufacture to the date of delivery. Packaging must be commercial and adhere to DLA Packaging Requirements for Procurement (RP001), with medical acquisitions specifically requiring marking according to Medical Marking Standard No. 1. All labels must include the contract or lot number and the manufacture, expiration, or retest date. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and payment. Offerors must be registered in the System for Award Management (SAM) and comply with the Buy American Act and DFARS safeguarding of covered defense information. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

POVIDONE-IODINE CLEANS

Solicitation # SPE2DP-27-T-0119

Solicitation SPE2DP-27-T-0119 is a fixed-price procurement by the Defense Logistics Agency for four one-gallon bottles of Povidone-Iodine Cleansing Solution, USP 7.5% active ingredient. This FDA-regulated drug must be delivered FOB Destination within five days of the award. The product has a total shelf life of 36 months, with a requirement that at least 31 months of shelf life remain upon delivery to the first government activity. Storage must be maintained at 25 degrees Celsius, with permitted excursions between 15 and 30 degrees Celsius. The contract mandates strict adherence to the DLA Master List of Technical and Quality Requirements and Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking. Packaging must be commercial and sealed to prevent damage, with specific requirements for hazardous materials under FED-STD-313 and TQ requirement IP025, or ASTM D3951 for non-hazardous materials. Suppliers must provide Safety Data Sheets and HCS labels in accordance with 29 CFR 1910.1200. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with the Buy American Act and Berry Amendment regarding domestic sourcing. Inspection and acceptance will occur at the destination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sodium Bicarbonate Injection ManufacturingThis subcontract involves the manufacturing of Sodium Bicarbonate 84mg/mL Injection in 50mL vials to support prime contractors on Department of Veterans Affairs pharmaceutical procurement projects. The scope of work encompasses the entire production process, including chemical synthesis, formulation, and the sterile filling and sealing of vials. All operations must be performed within the United States using automated vial filling lines and sterile cleanroom facilities. To ensure product safety and regulatory adherence, the manufacturer is required to maintain a unique NDC number and strictly follow FDA CGMP compliance. The final deliverable consists of finished, sterile Sodium Bicarbonate vials. This project is managed under Nac Pharmaceuticals for the Department of Veterans Affairs, falling under NAICS code 325412.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Sodium Bicarbonate Injection Vial Restricted to Made in America

Solicitation # 36E79726R0041

The Department of Veterans Affairs intends to award a firm-fixed requirements-type contract for Sodium Bicarbonate 84mg/mL Injection 50mL vials, with an estimated annual usage of 65,587 bottles. This procurement is restricted to suppliers with products manufactured in the United States in accordance with FAR 6.103-3 and will be issued in a commercial item format per FAR Part 12. The contract will support multiple agencies, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Centers, with distribution managed through the VA and DOD Pharmaceutical Prime Vendor Programs. The award will be granted to a single responsible offeror capable of providing an uninterrupted source of supply for a base period of one year, with four pre-priced one-year option periods. Under NAICS code 325412, the solicitation requires offerors to provide a unique NDC number and the exact drug name as it appears on the label. Strict labeling standards apply: the contractor's unique NDC label must be the only label on the product, and labels cannot be affixed over existing ones; however, they must allow VA labels to adhere securely on top. While glass bottles are acceptable, all packaging must be compatible with automated dispensing units such as Opti-fill and Baxter ATC Canisters. The solicitation is expected to be issued on October 21, 2026, with a tentative closing date of November 18, 2026, and all communications and submissions must be handled electronically via SAM.gov.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

6505--Imatinib Tablets

Solicitation # 36E79726R0036

The Department of Veterans Affairs is seeking an unrestricted procurement to establish a firm fixed price, indefinite-delivery requirements contract for Imatinib Mesylate Tablets in 100MG and 400MG strengths. This contract supports a wide range of federal entities, including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The award consists of a base year plus four pre-priced one-year option periods, with estimated annual quantities of 6,397 bottles for the 100MG tablets and 19,504 bottles for the 400MG tablets. Award will be based on the lowest evaluated price for proposals that meet all non-cost acceptability standards, including a review of past performance to determine contractor responsibility. Strict technical and regulatory requirements apply to this procurement. All products must be compatible with automated dispensing units and packaged in non-glass cylindrical bottles with specific dimensions and safety caps. Labeling must include a unique 11-digit NDC number and conform to GS1-128 or HIBCC HIBC bar-coding standards, as well as Drug Supply Chain Security Act (DSCSA) requirements for two-dimensional data matrix bar codes and serialized transaction information. Offerors must maintain an acceptable cGMP status with the FDA and provide an ANDA, NDA, or BLA. Proposals are due by October 30, 2026, and must be submitted in Word or PDF format via email.

Nac Pharmaceuticals (36E797)

POSTED

DEADLINE

Hydrogen Peroxide Topical Solution (USP) SupplierThis subcontract involves the supply of 3% stabilized Hydrogen Peroxide Topical Solution, USP, to prime contractors supporting Department of Defense projects under the Medical Supply Chain Pharm FSA. The supplier is responsible for manufacturing or sourcing over-the-counter stabilized solutions in 473ml bottles that strictly adhere to FDA regulations and United States Pharmacopeia standards. Key compliance requirements include the provision of current Material Safety Data Sheets and strict adherence to 49 CFR and 29 CFR regulations regarding the handling and transport of hazardous materials. The performance of this contract is centered in FPO 96671, with a response deadline set for October 21, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

4 days ago

DEADLINE

in 2 days

AI Contract Overview

This contract, identified as solicitation SPE2DP-26-T-4862, is for the procurement of Mefloquine Hydrochloride tablets, 250 mg, used as an antimalarial agent. The order consists of one package containing 25 tablets, with Teva Pharmaceuticals USA, Inc. listed as the manufacturer. The item is regulated by the FDA and is classified as a Type I item with a non-extendable shelf life of 36 months. Delivery is required within 20 days after receipt of the order, with a required delivery date of January 15, 2026, shipped FOB destination to Ellsworth AFB, South Dakota. The procurement is subject to strict technical and quality requirements, including DLA packaging requirements and Medical Marking Standard No. 1. Labels must include the NSN, NDC, quantity, unit of issue, manufacturer, CAGE code, date of manufacture, expiration or retest date, and the contract or lot number. Packaging must be commercial and sealed to protect contents from damage, with palletization following RP001 standards. The acquisition is managed by the Department of Defense Medical Supply Chain under NAICS code 325412, with inspection and acceptance occurring at the destination.

General Info

Procurement of Mefloquine tablets from Teva Pharmaceuticals for delivery to Ellsworth AFB.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

2900 DOOLITTLE DR BLDG 6000, ELLSWORTH AFB, SD, 57706-4821, USA

Set-Aside

NONE

Documents

SPE2DP-26-T-4862 RFQ - DLA Medical Supply Chain

19 pages · rfq

High

AI Contract Breakdown

Uniform Contract Format

Timeline

PhaseClosed

PostedSep 2

Solicitation

Response DeadlineSep 8

Deadline has passed

Submission Closed

09/08/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUSA

Organization / AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUSA

Contacts

ANGELA HARVEY

contact@example.gov

+1 (555) 000-0000

Full Description

MEFLOQUINE HYDROCHL
MEFLOQUINE HYDROCHLORIDE TABLETS
250 MG OF MEFLOQUINE HYDROCHLORIDE USP.
UNIT DOSE PG 25S
USED AS AN ANTIMALARIAL AGENT
U/I: PG (25 TABLETS)
.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
.
1 PG = 25 TT
.
LABELING AND MARKING.
LABELS SHALL INCLUDE: NSN, NDC, QUANTITY<(>,<)>
UNIT OF ISSUE, MANUFACTURER, CAGE CODE<(>,<)>
DATE OF MANUFACTURER, EXPIRATION, OR RETEST
DATE AND CONTRACT NUMBER/LOT NUMBER.
SHIPPING CONTAINER SHALL BE MARKED AS
SPECIFIED IN MEDICAL MARKING STANDARD
NUMBER 1.
.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
SPE2DP-26-T-4862
SECTION B
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00555-0171-78
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7015121170 0001 PG 1.000
NSN/MATERIAL:6505016103438
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be
SPE2DP-26-T-4862
SECTION B
PR: 7015121170 PRLI: 0001 CONT’D
as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
FY2922
FY2922 28TH MDG SGSM
CP 6053853468
2900 DOOLITTLE DR BLDG 6000
ELLSWORTH AFB SD 57706-4821
US
SHIP BY TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
FY2922
FY2922 28TH MDG SGSM
CP 6053853468
2900 DOOLITTLE DR BLDG 6000
ELLSWORTH AFB SD 57706-4821
US
M/F: (TCN) FM452860090028
RDD:
PROJ: TP 3
SUPP ADD: FY2922 SIG: J
FOR GOVERNMENT USE ONLY: (IPD) 15
DIC: A0A DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:01/15/2026
SPE2DP-26-T-4862 NSN/Part Number: 6505-01-610-3438 Quantity: 1 PG Purchase Request: 7015121170QTY: 1 Delivery: 20 days ADO